A detailed history of Nilsine Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nilsine Partners, LLC holds 17,451 shares of ABT stock, worth $1.79 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
17,451
Previous 18,156 3.88%
Holding current value
$1.79 Million
Previous $2 Billion 0.75%
% of portfolio
0.27%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $77,211 - $85,276
-705 Reduced 3.88%
17,451 $1.98 Billion
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $123,560 - $151,248
1,370 Added 8.16%
18,156 $2 Billion
Q3 2023

Nov 01, 2023

BUY
$95.53 - $114.62 $7,833 - $9,398
82 Added 0.49%
16,786 $1.63 Billion
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $43,536 - $48,509
432 Added 2.65%
16,704 $1.82 Billion
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $1.58 Million - $1.86 Million
16,272 New
16,272 $1.65 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.